Physician profile
Daniel Feingold
NPI 1568546034
$13,506.51
in general payments reported to CMS, 2019-2025
11 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what 76% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2021: $15.99 · 2022: $400 · 2023: $4,283 · 2024: $6,889 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $4,874 · Food and Beverage: $2,115 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $4,873.53 |
| Food and Beverage | $2,115.18 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,879.91 | 2022-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $592.89 | 2022-2025 | Eea, Signia |
| Covidien Lp | $325.00 | 2019 | |
| Biom'Up Sa | $196.12 | 2019 | |
| Integra Lifesciences Corporation | $174.10 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Virtual Incision Corporation | $140.00 | 2024 | Mira |
| Davol INC. | $60.79 | 2024 | Phasix Mesh |
| Kerecis Limited | $56.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acell, INC. | $50.78 | 2019 | |
| Ethicon US, LLC | $15.99 | 2021 | |
| Merck Sharp & Dohme LLC | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Feingold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.